Assessment of Disease Activity in Behcet by Complete Blood Count
Launched by ASSIUT UNIVERSITY · Nov 17, 2018
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
Behçet' s disease (BD) is a complex, inflammatory multisystem disorder characterized by recurrent attacks of oral ulcers, genital ulcers, cutaneous lesions, and inflammatory ocular finding. The vascular inflammatory change is known to be the main histopathology. There is no sensitive or specific laboratory test or pathologic findings , the diagnosis relies heavily on mucocutaneous manifestations and other clinical findings.
In the previous studies,In order to diagnose and monitor disease activity in BD, many cytokines and biomarkers have been identified such as increased blood levels of ne...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -Patient diagnosed as behcet disease by a rheumatologist
- • Age from 18 to 70 years old
- Exclusion Criteria:
- • - Skin diseases,
- • Autoimmune diseases,
- • Inflammatory or infectious diseases,
- • Allergy,
- • Subjects with chronic diseases such as cardiovascular disorders, diabetes mellitus, or hematological, kidney, or liver diseases, hypertension, or malignant diseases
- • unwilling to participate in the study
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
esraa omar, master
Study Chair
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials